| Not Yet Recruiting | Evaluation of Clinical Benefit and Safety Following CYFENDUS Administration for Post-Exposure Prophylaxis of A Anthrax | — | 2035-11-01 |
| Not Yet Recruiting | A Field Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Inhalational Anthrax Patients Inhalational Anthrax | — | 2027-05-30 |
| Not Yet Recruiting | Observational Study of Raxibacumab in Sporadic Cases of Systemic Anthrax Infections, Bacterial | — | 2027-05-01 |
| Not Yet Recruiting | Clinical Benefit and Safety of Raxibacumab in Patients With Symptomatic Inhalational Anthrax in a Mass Exposur Infections, Bacterial | Phase 4 | 2027-01-01 |
| Not Yet Recruiting | Observational Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Patients With Systemic Ant Anthrax | — | 2026-11-30 |
| Completed | Study Evaluating the Bioequivalence of Brincidofovir Form H and Form II Tablets in Healthy Adults Smallpox | Phase 1 | 2023-05-30 |
| Completed | Pharmacokinetics (PK) and Safety of Multiple Doses of Intranasal Naloxone in Healthy Adults Opioid Overdose | Phase 1 | 2022-03-28 |
| Completed | Study of SIAN Nasal Spray in Healthy Adults Cyanide Poisoning | Phase 1 | 2021-12-21 |
| Completed | A COVID-19 Study to Evaluate Safety and PK of COVID-HIG Administered Through IM, SC, or IV Routes to SARS-CoV- SARS-CoV-2 Infection | Phase 1 | 2021-12-07 |
| Completed | Universal Influenza A Vaccine in Healthy Adults Human Influenza | Phase 1 | 2021-12-01 |
| Completed | A COVID-19 Study to Evaluate Safety and Pharmacokinetics of COVID-HIGIV Administered in Healthy Adults COVID-19 | Phase 1 | 2020-12-24 |
| Completed | Velocity 2: An Anthrax Vaccine and Antibiotics Clinical Study Anthrax | Phase 2 | 2019-08-12 |
| Completed | VELOCITY: An Anthrax Vaccine Clinical Study Anthrax | Phase 3 | 2019-03-11 |
| Completed | Study in Healthy Volunteers Evaluating Safety and Pharmacokinetics of Zika Virus Immune Globulin (ZIKV-IG) Zika Virus Infection, Zika Virus Disease | Phase 1 | 2018-06-27 |
| Completed | Exploring Safety & Clinical Benefit of Anti-Influenza Immunoglobulin Intravenous in Hospitalized Adults With I Influenza A H3N2, Influenza A H1N1 | Phase 2 | 2017-11-17 |
| Terminated | A Study to Assess the Safety, Pharmacodynamics, and Immunogenicity of PXVX0047 Adenoviral Infection | Phase 1 | 2017-05-01 |
| Terminated | Safety and Pharmacokinetics of UV-4B Solution Administered Orally as Multiple Ascending Doses to Healthy Subje Viral Infection | Phase 1 | 2016-05-27 |
| Completed | VA-008 ACAM2000® Vaccination of Plasma Donors for the Production of VIGIV Smallpox Vaccine Adverse Reaction | Phase 4 | 2015-09-01 |
| Terminated | Study to Evaluate the Safety and Immunogenicity of an Oral HIV Vaccine in Healthy, HIV-uninfected Adults Healthy Volunteer, HIV Vaccine | Phase 1 | 2015-03-01 |
| Completed | Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed Infections, Bacterial | Phase 4 | 2015-02-24 |
| Enrolling By Invitation | BT-011 Pharmacokinetics of Botulism Antitoxin Heptavalent in Pediatric Patients Botulism | Phase 4 | 2014-10-01 |
| Completed | BT-010 Registry for the Evaluation of Safety and Clinical Outcomes in Patients Treated With Botulinum Antitoxi Botulism | — | 2014-10-01 |
| Completed | Study to Determine the Safety, Tolerability and Pharmacokinetics of UV-4B Solution Administered Orally in Heal Viral Infection | Phase 1 | 2014-07-01 |
| Completed | A Phase 1 Ascending Dose Study to Assess the Safety and Immunogenicity of Adenovirus Anthrax Vector Candidate Anthrax Infection | Phase 1 | 2013-11-01 |
| Completed | A Phase 2 Safety and Immunogenicity Study for an Anthrax Vaccine Using 3 Schedules and Two Dose Levels Anthrax | Phase 2 | 2013-01-01 |
| Completed | Ciprofloxacin BioThrax Co-Administration Study Anthrax | Phase 2 | 2012-12-01 |
| Completed | BioThrax® (Anthrax) Vaccine in Pregnancy Registry Pregnancy Complications, Pregnancy Outcome, Congenital Abnormalities | — | 2012-07-01 |
| Completed | Immunogenicity and Safety Study of a Three-Dose BioThrax® Regimen for Post-Exposure Prophylaxis in Healthy Adu Anthrax | Phase 3 | 2011-11-01 |
| Completed | ACAM2000® Myopericarditis Registry Myocarditis, Pericarditis | — | 2011-04-01 |
| Completed | Safety, Tolerability and Immunogenicity Study of AV7909 Anthrax Vaccine in Healthy Adults Bacillus Anthracis (Anthrax) Infection | Phase 1 | 2010-12-01 |
| Completed | VA-006 Vaccinia Vaccine (ACAM2000) for the Production of VIGIV Smallpox Vaccine Adverse Reaction | Phase 3 | 2010-09-13 |
| Completed | Safety and Pharmacokinetics Study of Human Monoclonal Antibody (AVP-21D9) Anthrax | Phase 1 | 2010-08-01 |
| Completed | Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1 Bird Flu, Influenza | Phase 1 | 2009-10-01 |
| Terminated | Hepatitis B Virus Antibody Booster Program for the Production of Hepatitis B Immune Globulin (HBIG) Healthy Volunteers | Phase 3 | 2009-09-01 |
| Completed | Post-licensure Department of Defense (DOD) Screening Accuracy Study in Military Personnel Smallpox | — | 2009-09-01 |
| Completed | Safety and Pharmacokinetics Study of Anthrax Immune Globulin Intravenous (AIGIV) Anthrax | Phase 1 / Phase 2 | 2009-02-01 |
| Completed | Safety Surveillance Study of ACAM2000® Vaccinia Vaccine Smallpox | — | 2008-12-01 |
| Completed | Safety Surveillance Cohort Study of Vaccinia Vaccine (ACAM2000®) Smallpox | — | 2008-12-01 |
| Completed | Immunogenicity, Safety and Tolerability of the Typhoid Fever Vaccine Candidate M01ZH09 in Healthy Adults Typhoid | Phase 2 | 2008-05-01 |
| Completed | Botulism Antitoxin Effects on Paralysis Induced by Botulinum Neurotoxins in the EDB Muscle Healthy Volunteers | Phase 1 | 2008-02-01 |
| Enrolling By Invitation | VA-005 Clinical Outcomes of VIGIV Treatment of Smallpox Vaccination Complications or Vaccinia Infection Complication of Smallpox Vaccination | — | 2007-08-01 |
| Completed | Safety and Pharmacokinetic Study of Anthrax Immune Globulin Derived From Human Serum Symptoms of Inhalational Anthrax | Phase 1 | 2007-07-01 |
| Terminated | CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell Lymphoma T-cell Lymphoma | Phase 2 | 2007-05-01 |
| Completed | Safety Study of 7 Botulinum Antitoxin Serotypes Derived From Horses Healthy | Phase 1 | 2006-07-01 |
| Completed | HuMax-CD4 in Non-Cutaneous T-Cell Lymphoma T Cell Lymphoma | Phase 2 / Phase 3 | 2005-08-01 |
| Completed | Effect of Dose, Safety, Tolerability of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination Smallpox | Phase 2 | 2003-01-01 |
| Completed | Dose Study of ACAM2000 Smallpox Vaccine in Previously Vaccinated Adults Smallpox | Phase 2 | 2003-01-01 |